Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor
- PMID: 1280833
- PMCID: PMC50608
- DOI: 10.1073/pnas.89.23.11637
Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor
Abstract
Rabbits were immunized with a synthetic phosphopeptide corresponding to a major autophosphorylation site of p185neu/erbB2 to determine the feasibility of producing tyrosine-phosphopeptide-specific antibodies. A series of adsorption and affinity chromatography steps were used to select antibodies with the desired reactivity. Immunoblot experiments showed that the resulting serum is highly specific for tyrosine-phosphorylated forms of p185 and the related epidermal growth factor receptor. The serum recognized these two receptors selectively when compared to five other receptor tyrosine kinases and several phosphorylated substrates. The serum is compatible with tissue-based assays since it detected tyrosine phosphorylation of the epidermal growth factor receptor in immunofluorescence experiments on permeabilized cells. The generality of the procedures used means that similar anti-tyrosine phosphopeptide sera can be produced that recognize other tyrosine kinases and substrates. Such sera will have numerous applications in research and clinical settings.
Similar articles
-
p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2.Oncogene. 1990 Jun;5(6):879-83. Oncogene. 1990. PMID: 1694290
-
Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor.Cancer Res. 1995 May 1;55(9):1946-55. Cancer Res. 1995. PMID: 7728765
-
Immunodetection of the ligand-activated receptor for epidermal growth factor.Growth Factors. 1991;4(4):305-16. doi: 10.3109/08977199109043916. Growth Factors. 1991. PMID: 1722417
-
Phosphotyrosine antibodies as probes for activated oncogene products endowed with tyrosine kinase activity.Ann Ist Super Sanita. 1991;27(1):175-81. Ann Ist Super Sanita. 1991. PMID: 1720292 Review.
-
Antibodies for phosphotyrosine: analytical and preparative tool for tyrosyl-phosphorylated proteins.Anal Biochem. 1988 Jul;172(1):1-7. doi: 10.1016/0003-2697(88)90403-4. Anal Biochem. 1988. PMID: 2461110 Review. No abstract available.
Cited by
-
Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation.Biochem J. 1994 Nov 1;303 ( Pt 3)(Pt 3):893-9. doi: 10.1042/bj3030893. Biochem J. 1994. PMID: 7980459 Free PMC article.
-
Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors.Am J Pathol. 1996 Feb;148(2):549-58. Am J Pathol. 1996. PMID: 8579117 Free PMC article.
-
Directed evolution of the forkhead-associated domain to generate anti-phosphospecific reagents by phage display.J Mol Biol. 2012 Nov 23;424(1-2):88-103. doi: 10.1016/j.jmb.2012.09.006. Epub 2012 Sep 15. J Mol Biol. 2012. PMID: 22985966 Free PMC article.
-
Altered localization and cytoplasmic domain-binding properties of tyrosine-phosphorylated beta 1 integrin.J Cell Biol. 1994 Sep;126(5):1299-309. doi: 10.1083/jcb.126.5.1299. J Cell Biol. 1994. PMID: 7520449 Free PMC article.
-
Next-Generation in vivo Modeling of Human Cancers.Front Oncol. 2018 Oct 10;8:429. doi: 10.3389/fonc.2018.00429. eCollection 2018. Front Oncol. 2018. PMID: 30364119 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous